TLDR:
- Overjet, a dentistry AI developer, raises $53.2 million in a series C round.
- The company’s AI programs help spot tooth decay and gum disease, leading to more accurate diagnoses and faster reimbursements.
In a recent funding round, Overjet, a dentistry AI developer, secured $53.2 million to expand its platform that aids in the detection of tooth decay and gum disease. This marks the largest single investment in dentistry AI for the Boston-based company. With the backing of investors such as March Capital and General Catalyst, Overjet aims to build a unified platform for dentists’ offices and payers, streamlining workflows and improving patient care.
Since receiving its fourth FDA clearance for its AI programs, Overjet has become a leader in the dental AI category, reaching thousands of dentists and partnering with payers covering over 120 million people. The company’s innovative technology enhances the efficiency and quality of dental care by providing more accurate diagnoses and treatment recommendations.
Overjet’s AI models have shown promise in reducing missed carious lesions on X-ray images and improving detection rates among patients aged 12 and up. By incorporating objective AI programs into the dental decision-making process, the company aims to facilitate faster and more consistent reimbursements, ultimately benefitting both patients and insurers.
CEO Wardah Inam envisions Overjet’s platform as a true operating system for dental organizations, allowing for real-time benefits decisions and improved member experiences. As the company continues to innovate in the field of dentistry AI, it seeks to prioritize patient care and revolutionize the way dental pathologies are diagnosed and treated.
